Effect of food on everolimus absorption: Quantification in healthy subjects and a confirmatory screening in patients with renal transplants

Pharmacotherapy

Volumn 22, Issue 2 I, 2002, Pages 154-159

  Kovarik, John M ^a   Hartmann, Stefan ^a   Figueiredo, Joaquim ^a   Rordorf, Christiane ^a   Golor, Georg ^b   Lison, Arno ^c   Budde, Klemmens ^d   Neumayer, Hans H ^d  

^a NOVARTIS PHARMA AG   (Switzerland)

^b PAREXEL INTERNATIONAL   (United States)

^c Central Hospital   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG HALF LIFE; FAT INTAKE; FOOD INTAKE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; PHASE 1 CLINICAL TRIAL;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; CYCLOSPORINE; DIETARY FATS; DRUG INTERACTIONS; FASTING; HALF-LIFE; HEADACHE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; PREDNISONE; SIROLIMUS; TIME FACTORS;

EID: 0036151699     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.3.154.33542     Document Type: Article

References (17)

1. SDZ RAD, a new rapamycin derivative: Pharmacological properties in vitro and in vivo
2. SDZ RAD, an new rapamycin derivative: Synergism with cyclosporine
3. Chemical modification of rapamycin: The discovery of SDZ RAD
4. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs
5. Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients
6. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: Pharmacokinetics, exposure-response relationships, and influence on cyclosporine
7. Drug, meal and formulation interactions influencing drug absorption after oral administration
8. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
9. Effects of dietary fat on drug absorption
10. Effects of food on clinical pharmacokinetics
11. Physicochemical and physiological mechanisms for the effect of food on drug absorption: The role of lipids and pH
12. Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation
13. Rationale for the development of Sandimmune Neoral
14. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: Comparison with rapamycin
15. The effect of a high-fat meal on the oral bioavailability of the immunosuppressant sirolimus (rapamycin)